Grant: Doctoral: Vanier Canada Graduate Scholarships
University of Toronto
$150,000.00
Amyloid beta induced inflammation and its resolution by omega-3 fatty acids in a mouse model of Alzheimer's Disease
EF 2013-14
Résumé
Alzheimer's Disease is a devastating, progressive and ultimately fatal neurological disease with no known cure. Currently, 500 000 Canadians suffer from Alzheimer's Disease and that number is expected to double over the next 30 years as the population ages. Consumption of omega-3 fatty acids, particularly DHA, a fatty acid in fish, have been associated with decreased incidence and severity of Alzheimer's Disease, but these results remain controversial and its mechanism of action is not understood. Recently, it was discovered that the resolution, or ending, of inflammation is an active process mediated by a class of molecules derived from omega 3s, collectively referred to as specialized pro-resolving mediators, presenting a possible mechanism for the protective effects of DHA. In these studies, we will characterize how inflammation begins, peaks, and resolves in a mouse model of Alzheimer's Disease. We will then investigate the role of omega 3 fatty acids in modulating inflammation in our Alzheimer's Disease model by feeding mice fish oil and by using a genetically modified mouse that can produce high levels of DHA and omega 3 fatty acids. We will also use a variety of techniques to discover what molecules derived from omega 3s exert these effects. This work could uncover the mechanism for the protective effects of fish oil and DHA consumption on Alzheimer's Disease that have been noted in human observational studies. It could also uncover novel products of DHA and other long chain omega 3 fatty acids that are responsible for these protective effects and could thus present new targets for the prevention and treatment of Alzheimer's Disease.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
299916
Name
Hopperton Kathryn E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Amyloid beta induced inflammation and its resolution by omega-3 fatty acids in a mouse model of Alzheimer's Disease
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Alzheimer'S Disease; Docosahexaenoic Acid; Neuroinflammation; Omega-3 Fatty Acids; Resolution Of Inflammation; Specialized Pro-Resolving Mediators
Abstract
Alzheimer's Disease is a devastating, progressive and ultimately fatal neurological disease with no known cure. Currently, 500 000 Canadians suffer from Alzheimer's Disease and that number is expected to double over the next 30 years as the population ages. Consumption of omega-3 fatty acids, particularly DHA, a fatty acid in fish, have been associated with decreased incidence and severity of Alzheimer's Disease, but these results remain controversial and its mechanism of action is not understood. Recently, it was discovered that the resolution, or ending, of inflammation is an active process mediated by a class of molecules derived from omega 3s, collectively referred to as specialized pro-resolving mediators, presenting a possible mechanism for the protective effects of DHA. In these studies, we will characterize how inflammation begins, peaks, and resolves in a mouse model of Alzheimer's Disease. We will then investigate the role of omega 3 fatty acids in modulating inflammation in our Alzheimer's Disease model by feeding mice fish oil and by using a genetically modified mouse that can produce high levels of DHA and omega 3 fatty acids. We will also use a variety of techniques to discover what molecules derived from omega 3s exert these effects. This work could uncover the mechanism for the protective effects of fish oil and DHA consumption on Alzheimer's Disease that have been noted in human observational studies. It could also uncover novel products of DHA and other long chain omega 3 fatty acids that are responsible for these protective effects and could thus present new targets for the prevention and treatment of Alzheimer's Disease.
Competitiondate
201311
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Hopperton, Kathryn E
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~